Cardiovascular

The following guidelines have been approved by the Barking and Dagenham, Havering and Redbridge Area Prescribing sub-Committees (APC). They have been developed in association with the relevant clinicians in both primary and secondary care, where applicable.

Please note that the Havering and Redbridge pages have been redirected to facilitate updates.

NHSE

• Lipid management pathway
• Statin intolerance pathway
• Sacubitril valsartan GP fact sheet for chronic heart failure with reduced ejection fraction

UCLP Partners

• Initiating anticoagulation for stroke prevention in non-valvular atrial fibrillation primary care guide
• Initiating anticoagulation for stroke prevention in non-valvular atrial fibrillation pathway

Barts Health

Prevention of stroke and embolism for nonvalvular atrial fibrillation

• Apixaban
• Dabigatran
• Edoxaban
• Rivaroxaban

Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism:

• Apixaban
• Dabigatran
• Edoxaban
• Rivaroxaban

BHRUT

• NOAC follow up and monitoring checklist in AF/VTE patients in primary care

London Cardiac Networks

• Prescribing anti-platelet agents following stroke and TIAs
• Prasugrel guidance post NICE guidance
• Ticagrelor guideline post NICE guidance

Clinical Effectiveness Group

• Third Party Prescribing for Atrial Fibrillation
• Atrial fibrillation Improving anticoagulation: update (2014)
• Atrial fibrillation Improving anticoagulation (2012)